Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the safety and compare the bioavailability of fenofibric acid from 2 different dosage strengths of ABT-335.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Abbott
• Treatments: Fenofibrate; Fenofibric acid

Criteria

Inclusion Criteria:

• A condition of general good health

• BMI 18 to 29

Exclusion Criteria:

• Currently enrolled in another clinical study

• Females who are pregnant or breast-feeding